Deborah B. Carosella's Insider Trades & SAST Disclosures
Deborah B. Carosella's most recent trade in Arcadia Biosciences Inc was a trade of 10,909 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Deborah B. Carosella.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcadia Biosciences Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 10,909 | 13,255 | - | - | Stock Option (Right to Buy) | |
| Arcadia Biosciences Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 937 | 2,346 | - | - | Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 9.50 per share. | 04 Jun 2022 | 7,059 | 36,588 (0%) | 0% | 9.5 | 67,061 | Common Stock |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2022 | 7,059 | 0 | - | - | Restricted Stock Unit | |
| Arcadia Biosciences Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 23,620 | 56,408 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 9,474 | 9,474 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,059 | 7,059 | - | - | Restricted Stock Unit | |
| Arcadia Biosciences Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,935 | 32,788 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 8,303 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 11.64 per share. | 01 Jun 2021 | 8,303 | 29,529 (0%) | 0% | 11.6 | 96,647 | Common Stock |
| Arcadia Biosciences Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 21,853 | 21,853 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 15 Oct 2020 | 2,200 | 21,226 (0%) | 0% | 10.4 | 22,792 | Common Stock |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 2,200 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 8,303 | 8,303 | - | - | Right to Buy Restricted Stock Unit (RSU) | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 6,000 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Deborah B. Carosella | Director | Grant, award, or other acquisition of securities at price $ 10.99 per share. | 28 May 2020 | 6,000 | 19,026 (0%) | 0% | 11.0 | 65,940 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges